As of 2025-06-02, the Intrinsic Value of HOB Biotech Group Corp Ltd (688656.SS) is 6.40 CNY. This 688656.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 95.83 CNY, the upside of HOB Biotech Group Corp Ltd is -93.30%.
The range of the Intrinsic Value is 4.48 - 11.49 CNY
Based on its market price of 95.83 CNY and our intrinsic valuation, HOB Biotech Group Corp Ltd (688656.SS) is overvalued by 93.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 4.48 - 11.49 | 6.40 | -93.3% |
| DCF (Growth 10y) | 10.73 - 28.24 | 15.56 | -83.8% |
| DCF (EBITDA 5y) | 90.78 - 117.30 | 102.42 | 6.9% |
| DCF (EBITDA 10y) | 81.26 - 121.71 | 98.65 | 2.9% |
| Fair Value | 2.75 - 2.75 | 2.75 | -97.13% |
| P/E | 15.29 - 23.06 | 17.99 | -81.2% |
| EV/EBITDA | 18.50 - 77.56 | 39.37 | -58.9% |
| EPV | (12.41) - (17.58) | (15.00) | -115.6% |
| DDM - Stable | 4.32 - 14.59 | 9.45 | -90.1% |
| DDM - Multi | 12.93 - 31.83 | 18.16 | -81.0% |
| Market Cap (mil) | 6,043.04 |
| Beta | 2.92 |
| Outstanding shares (mil) | 63.06 |
| Enterprise Value (mil) | 6,039.15 |
| Market risk premium | 6.13% |
| Cost of Equity | 10.15% |
| Cost of Debt | 5.00% |
| WACC | 10.04% |